MoonLake Immunotherapeutics
MLTX
#3795
Rank
$2.52 B
Marketcap
$39.86
Share price
0.05%
Change (1 day)
-17.98%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2024 (TTM): -$0.15 Billion USD

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -$54.13 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 -$0.15 Billion164.38%
2023 -$54.13 Million-16.81%
2022 -$65.07 Million